COVID-19 Patients on Extracorporeal Membrane Oxygenation Did Not Experience Increased Prevalence of Intracranial Hemorrhage
- PMID: 35984062
- DOI: 10.1097/CCM.0000000000005572
COVID-19 Patients on Extracorporeal Membrane Oxygenation Did Not Experience Increased Prevalence of Intracranial Hemorrhage
Conflict of interest statement
Dr. Singh received funding from Baxter. Dr. King received funding from Untied Therapeutics, Actelion, and Boehringer-Ingelheim Pharmaceuticals. The remaining authors have disclosed that they do not have any potential conflicts of interest.
Comment in
-
The authors reply.Crit Care Med. 2022 Sep 1;50(9):e723-e724. doi: 10.1097/CCM.0000000000005599. Epub 2022 Aug 15. Crit Care Med. 2022. PMID: 35984063 No abstract available.
Comment on
-
Intracranial Hemorrhages on Extracorporeal Membrane Oxygenation: Differences Between COVID-19 and Other Viral Acute Respiratory Distress Syndrome.Crit Care Med. 2022 Jun 1;50(6):e526-e538. doi: 10.1097/CCM.0000000000005441. Epub 2022 Jan 12. Crit Care Med. 2022. PMID: 35020672 Free PMC article.
References
-
- Seeliger B, Doebler M, Hofmaenner DA, et al.: Intracranial hemorrhages on extracorporeal membrane oxygenation: Differences between COVID-19 and other viral acute respiratory distress syndrome. Crit Care Med 2022; 50:e526–e538
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical